you are viewing a single comment's thread.
Jefferies price target is $68 (Feb 2012).Valuation difference between them and JPM/GS is about $7B.It will be difficult to make an additional $7B (on top of $13B) in rare kidney disease indication.
there are stocks to short in this market. and its not this one. look at the graph. and dont be an idiot.